Market Place
Sourcing Support
Scilex Holding changes record date for dividend to April 11, 2025
10 Mar 2025 //
GLOBENEWSWIRE
Scilex Lockup Period Extended To April 14, 2025, By U.S. Court
31 Jan 2025 //
GLOBENEWSWIRE
Scilex`s ELYXYB® Acute Pain sNDA Acknowledged By U.S. FDA
22 Jan 2025 //
GLOBENEWSWIRE
Scilex Files Quarterly Report Ending September 30, 2024
21 Jan 2025 //
GLOBENEWSWIRE
Scilex To File Supplemental NDA With FDA For Elyxyb Acute Pain
21 Jan 2025 //
GLOBENEWSWIRE
Scilex Note Holders Fund Gloperba® Ex-U.S. Licensing Agreement
21 Jan 2025 //
GLOBENEWSWIRE
Scilex Extends Maturity Date Of Secured Note To Oramed, Dec 2025
21 Jan 2025 //
GLOBENEWSWIRE
Scilex Holding Regains Nasdaq Compliance Under Rule 5250(c)(1)
21 Jan 2025 //
GLOBENEWSWIRE
Scilex Amends License To Commercialize FDA-Approved Gloperba®
16 Jan 2025 //
GLOBENEWSWIRE
Scilex Highlights Ztlido® Data Versus Lidocaine 5% Patch
13 Jan 2025 //
GLOBENEWSWIRE
Scilex Holding Changes Record Date for Preferred Stock Dividend
30 Dec 2024 //
GLOBENEWSWIRE
Scilex Holding Company Makes Early Payment for Growth
16 Dec 2024 //
GLOBENEWSWIRE
Scilex Closes $17M Registered Direct Offering
13 Dec 2024 //
GLOBENEWSWIRE
Scilex Holding Announces $17M Registered Direct Offering
12 Dec 2024 //
GLOBENEWSWIRE
Scilex Bio Reports Ph 2 Trial Enrollment for Obesity Results
11 Dec 2024 //
GLOBENEWSWIRE
Scilex Bio Reports KDS2010 Phase 2 Alzheimer’s Trial Enrollment
11 Dec 2024 //
GLOBENEWSWIRE
Scilex Partners IPMC & Bio Open Innovation for Obesity & Alzheimer
10 Dec 2024 //
GLOBENEWSWIRE
NeuroBiogen & Scilex Bio Enter Binding Term Sheet for Licensing
10 Dec 2024 //
GLOBENEWSWIRE
Scilex Holding Company Announces Receipt of Notice from Nasdaq
22 Nov 2024 //
GLOBENEWSWIRE
Scilex to Present Data at 2024 ACR Convergence Conference
15 Nov 2024 //
GLOBENEWSWIRE
Semnur Pharmaceuticals Files S-4 for Business Combo with Denali
06 Nov 2024 //
GLOBENEWSWIRE
Scilex Pharma Announces FDA Meeting for SP-103 Path Forward
30 Oct 2024 //
GLOBENEWSWIRE
Scilex Reiterates Info on Short Selling of Common Stock
29 Oct 2024 //
GLOBENEWSWIRE
Scilex Sets Nov. 7 Record Date for Preferred Stock Dividend
28 Oct 2024 //
GLOBENEWSWIRE
Semnur Provides Timing To File Registration Statement In October
16 Oct 2024 //
GLOBENEWSWIRE
Scilex Explores Value Maximization Options For Scilex Pharmaceuticals
16 Oct 2024 //
GLOBENEWSWIRE
Scilex Holding Announces Closing Of $50 Million Convertible Financing
08 Oct 2024 //
GLOBENEWSWIRE
Scilex Holding Provides Preliminary Q3 2024 Financial Results
08 Oct 2024 //
GLOBENEWSWIRE
Scilex Company Announces Signing of $50 Million Convertible Financing
07 Oct 2024 //
GLOBENEWSWIRE
Hapbee Appoints Mr. Abdulla Al Zain to Board of Directors
26 Sep 2024 //
GLOBENEWSWIRE
Scilex Announces Continuing Support From Endeavor
18 Sep 2024 //
GLOBENEWSWIRE
Scilex Holding Receives NABP Drug Distributor Accreditation
12 Sep 2024 //
GLOBENEWSWIRE
Scilex Announces Presentation At Rheumatology Conference
05 Sep 2024 //
GLOBENEWSWIRE
Scilex To Present On ZTlido At PAINWeek Conference In Las Vegas
30 Aug 2024 //
GLOBENEWSWIRE
Scilex Holding Gets FDA Approval for Precision Dosing GLOPERBA® Label
29 Aug 2024 //
GLOBENEWSWIRE
Scilex To Get New ELYXYB Patent For Acute Pain Treatment
21 Aug 2024 //
GLOBENEWSWIRE
Scilex Holding Provides Preliminary July 2024 Financial Results
01 Aug 2024 //
GLOBENEWSWIRE
Scilex Holding Company Publishes First Sustainability Report
24 Jul 2024 //
GLOBENEWSWIRE
Scilex Appoints Annu Navani To Board Of Directors
23 Jul 2024 //
GLOBENEWSWIRE
Semnur And Denali Capital Enter LOI For Business Combination
02 Jul 2024 //
GLOBENEWSWIRE
Scilex Holding Partners With National Distributor Endeavor Distribution LLC
20 Jun 2024 //
GLOBENEWSWIRE
Scilex Present Poster on ELYXYB® (celecoxib oral solution) at the AHS
13 Jun 2024 //
GLOBENEWSWIRE
Scilex Holding Company Announces That Many National Pharmacy Chains GLOPERBA®
11 Jun 2024 //
GLOBENEWSWIRE
Scilex Holding Company Announces 5-Year Term of $100 Million Financing
11 Jun 2024 //
GLOBENEWSWIRE
Scilex Announces GLOPERBA Stocking Underway Across US Wholesalers
10 Jun 2024 //
GLOBENEWSWIRE
Scilex: FDA Approves sNDA For Gloperba® US Launch Week Of June 10th 2024
06 Jun 2024 //
GLOBENEWSWIRE
Scilex Alleges Illegal Stock Manipulation Writes To Regulators
30 May 2024 //
GLOBENEWSWIRE
Scilex Letter To Us House: On Illegal Stock Market Manipulation
24 May 2024 //
GLOBENEWSWIRE
Scilex Added To Msci Index: Global Microcap Companies Inclusion
24 May 2024 //
GLOBENEWSWIRE
Scilex Provides Info On Manipulative Short Selling Of Its Common Stock
13 May 2024 //
GLOBENEWSWIRE
Scilex Holding Company Announces $15 Million Registered Direct Offering
24 Apr 2024 //
GLOBENEWSWIRE
Scilex Provides Q1 2024 ZTlido Sales, Plans 2024 Ramp for Opioid Sparing Product
16 Apr 2024 //
GLOBENEWSWIRE
Scilex Launches Co-Pay Programs, Expands Medicaid Access
09 Apr 2024 //
GLOBENEWSWIRE
Scilex Announces that the U.S. Bankruptcy Court has Extended the Lockup Period
27 Mar 2024 //
GLOBENEWSWIRE
Scilex Announces New Out-of-Pocket Costs for Commercially Insured Patients
21 Mar 2024 //
GLOBENEWSWIRE
Scilex Company Announces a Settlement Agreement with Takeda Pharma Paragraph IV
20 Mar 2024 //
GLOBENEWSWIRE
Scilex Holding Company Announces Repayment in Full of the Remaining Balance
19 Mar 2024 //
GLOBENEWSWIRE
Scilex Provides Responses to Composition Questions Related to its ELYXYB Patent
18 Mar 2024 //
GLOBENEWSWIRE
Scilex Entered into a Agreement with Virpax Pharmaceuticals
15 Mar 2024 //
GLOBENEWSWIRE
Scilex Holding Announces Issuance of Halal Certification for its ZTlido® product
15 Mar 2024 //
GLOBENEWSWIRE
